Tempus AI Inc (TEM)
A research Signal Score of unusual activity and the signals behind it. Not advice, not a prediction, not yet backtested.
Also measured against its sector ETF (IGV).
Our last 30 days of resolved calls came true 18% of the time.See the track record →
Figures reflect the most recent reported period. Margins, ROE and growth are percentages; Debt/Equity and Current ratio are ratios.
A generic 2:1 reward-to-risk example (about a 10% stop and 20% target). Illustrative and educational, not advice. Set your own levels for your risk tolerance.
- QualityRevenue growing 37% y/y-2
- Prediction marketsPrediction markets lean bearish on rate-sensitive growth (-6 pts)-6
- VolumeNo intraday volume on the free data tier — this factor is disabled, not faked.+0
Score uses live volume/momentum/breakout signals today; insider buying, short interest, options flow and social velocity layer in as those sources come online. How it works →
🤖 The dominant catalyst is product/data-business momentum, reinforced by MRD testing expansion and new precision-oncology partnerships, with Q3 results supporting the platform thesis. Continuation likelihood over the next few weeks is moderate (roughly 40–50%), since momentum headlines can fade and cash-return concerns may cap follow-through. Informational only — not financial advice.
- Tempus AI (TEM) Surged on Data Business Momentum and MRD Testing ExpansionYahoo · 2026-11-10
- Tempus’ Partner Blood Cancer United Launches Dare To Dream REALworld: AML, Patient-Centered Initiative Co-Founded With Rally Foundation For Childhood Cancer ResearchBenzinga · 2026-11-10
- SOTERIA Collaborates with Tempus to Advance Precision Oncology for U.S. Military and Veterans Battling CancerYahoo · 2026-11-09
- SOTERIA Precision Medicine Foundation Partners With Tempus To Provide Personalized, Data-Driven Cancer Treatment Insights, Genomic Sequencing To U.S. MilitaryBenzinga · 2026-11-09
- CNH Industrial, Planet Labs, Ferguson Enterprises And Other Big Stocks Moving Higher On MondayBenzinga · 2026-11-09
Any AI summary is an interpretation of public news, not advice or a price target.